Today's discussion on unraveling BPC 157 Peptide Podcast Por Infinity Peptides arte de portada

Today's discussion on unraveling BPC 157 Peptide

Today's discussion on unraveling BPC 157 Peptide

De: Infinity Peptides
Escúchala gratis

OFERTA POR TIEMPO LIMITADO | Obtén 3 meses por US$0.99 al mes

$14.95/mes despues- se aplican términos.

We will discuss the preclinical trial information on Bpc157 what have we heard what have we experienced, along with where does it come from.

‘RSSVERIFY’

Infinity Premier Consulting LLC Ciencia Higiene y Vida Saludable
Episodios
  • “Immune Modulation Unpacked: The Science of Thymosin Alpha-1”

    “Immune Modulation Unpacked: The Science of Thymosin Alpha-1”
    Jan 12 2026

    An evidence-based breakdown of Thymosin Alpha-1 (TA-1) covering immune mechanisms, preclinical research, human clinical trials, safety data, and ongoing studies in infection, sepsis, and cancer.
    Más Menos
    38 m
  • Tesamorelin from bench to bedside FDA approval

    Tesamorelin from bench to bedside FDA approval
    Jan 5 2026

    This episode is designed for listeners interested in clinical research, peptide science, endocrinology, and translational medicine, offering an evidence-based perspective without speculation or medical advice.

    Topics include:

    • Tesamorelin peptide mechanism of action
    • Preclinical and animal studies
    • Phase II and Phase III clinical trial data
    • FDA approval and HIV-associated lipodystrophy
    • Growth hormone, IGF-1, and metabolic effects
    • Safety, limitations, and ongoing research
    Más Menos
    12 m
  • Growth hormone secretagogue cjc1295 and Ipamorelin

    Growth hormone secretagogue cjc1295 and Ipamorelin
    Dec 29 2025

    This episode is designed for listeners interested in clinical research, peptide science, endocrinology, and translational medicine, offering an evidence-based perspective without speculation or medical advice.

    Topics include:

    • Tesamorelin peptide mechanism of action
    • Preclinical and animal studies
    • Phase II and Phase III clinical trial data
    • FDA approval and HIV-associated lipodystrophy
    • Growth hormone, IGF-1, and metabolic effects
    • Safety, limitations, and ongoing research
    Más Menos
    13 m
Todavía no hay opiniones